Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.24.1.u1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
SCHEDULE OF OTHER CURRENT ASSETS

Other current assets consisted of the following as of March 31, 2024 and December 31, 2023:

 

    March 31,
2024
    December 31,
2023
 
Lab supplies   $ 1,154     $ 1,227  
Prepaid expenses     387       590  
Other     57       24  
Total other current assets   $ 1,598     $ 1,841  
SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE

    2024     2023  
    Three Months Ended  
    March 31,  
    2024     2023  
Basic weighted average number of common shares     4,370       4,307  
Potential dilutive effect of stock-based awards     14       1  
Diluted weighted average number of common shares     4,384       4,308  
SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

    2024     2023  
    Three Months Ended  
    March 31,  
    2024     2023  
Options     288       526  
Restricted stock units (RSUs)     207       219  
Anti-dilutive securities     495       745